Miltenyi Biotec Reinvests in Montgomery County with New Headquarters

Published on :

Global biotechnology business Miltenyi Biotec is expanding its operations in Maryland and transferring its North American headquarters to Gaithersburg. The company is working on expanding its 1201 Clopper Road facility to support additional manufacturing, research and development, quality assurance, and more. Miltenyi Biotec plans to add 130 new full-time jobs in Maryland, giving it a total of 300 employees in the state by the end of the year.

Global Cell and Gene Therapy Company Miltenyi Biotec is Expanding its Operations in Maryland 

Published on :

BALTIMORE, MD (March 15, 2022) — Global biotechnology business Miltenyi Biotec is expanding its operations in Maryland and transferring its North American headquarters to Gaithersburg. The company is working on expanding its 1201 Clopper Road facility to support additional manufacturing, research and development, quality assurance, and more. Miltenyi Biotec plans to add 130 new full-time jobs in Maryland, giving it a total of 300 employees in the state by the end of the year.
“By selecting Maryland for its North American headquarters, Miltenyi Biotec will help us continue growing our industry and further our efforts in remaining one of the top 10 life sciences clusters in the nation,” said Governor Larry Hogan. “We welcome the company’s continued investment in Montgomery County and look forward to supporting their efforts in Maryland and across the globe.”
This is not the company’s first investment in Maryland in recent years. In 2014, Miltenyi Biotec acquired Gaithersburg’s lentiviral vector manufacturing company Lentigen Technology Inc., which develops and commercializes therapeutics for stem cell therapies and oncology. In 2017, the company acquired Living Pharma, Inc., a startup of the University of Maryland, Baltimore that develops personalized cell therapy for targeted individuals’ cancers and diseases. Both became part…

Biomanufacturing Career Tips for a Booming Life Sciences Market

Published on :

WorkForce Genetics recently hosted the webinar event, “Navigating Your Biomanufacturing Career.” The webinar, which was held in March 2022, brought together industry thought leaders for a robust panel discussion about biomanufacturing career tips for the BioHealth Capital Region’s booming job market. 

Miltenyi Biotec promotes Markus Weiss to Executive Vice President

Published on :

Markus Weiss, who in this role is responsible for supporting the North American Business Units and Divisions has 18 years of experience in operationalizing strategy, preserving and growing value, scaling culture as well as business transformations. He is experienced in divisional, regional and country level leadership roles in technology, life science, manufacturing, construction and financial services.

Flow Cytometry: Principles, Methods and Applications

Published on :

This four day program is ideal for those who are looking for an in-depth, hands-on introduction to Flow Cytometry. Team taught by active researchers (50+ yrs of combined FACs experience), [….]

Biotech Boom Magnifies Biomanufacturing Capacity and Workforce Challenges

Biotech Boom Magnifies Biomanufacturing Capacity and Workforce Challenges
Published on :

The ongoing pandemic response by the biopharma industry has been historic. Biotech companies and contract development and manufacturing organizations, along with the entire supply chain, have worked together to develop several SARS-CoV-2 vaccines, achieved Emergency Use Authorization(EUA) from the FDA, and began delivering desperately needed protection into people’s arms in less than a calendar year.

5 Questions With… 2020 Recap

5 Questions With 2020
Published on :

In 2020 we introduced a new series titled “5 Questions With…” in an effort to spotlight individuals from across the BioHealth Capital Region and beyond. Providing this platform has allowed us to help share the stories of industry peers and show that there isn’t a single “right” way to becoming an industry success.

5 Questions with Mike O’Mara, VP of Industrial Business Services, Miltenyi Biotec

Published on :

Mike O’Mara has more than 27 years of experience in biopharmaceutical contract manufacturing encompassing microbial, mammalian, and cell/Gene therapy manufacturing processes ranging from Preclinical/Phase I through Commercial.